These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 19165859)
1. Shikonin exerts antitumor activity via proteasome inhibition and cell death induction in vitro and in vivo. Yang H; Zhou P; Huang H; Chen D; Ma N; Cui QC; Shen S; Dong W; Zhang X; Lian W; Wang X; Dou QP; Liu J Int J Cancer; 2009 May; 124(10):2450-9. PubMed ID: 19165859 [TBL] [Abstract][Full Text] [Related]
2. Shikonin extracted from medicinal Chinese herbs exerts anti-inflammatory effect via proteasome inhibition. Lu L; Qin A; Huang H; Zhou P; Zhang C; Liu N; Li S; Wen G; Zhang C; Dong W; Wang X; Dou QP; Liu J Eur J Pharmacol; 2011 May; 658(2-3):242-7. PubMed ID: 21392503 [TBL] [Abstract][Full Text] [Related]
3. The tumor proteasome is a primary target for the natural anticancer compound Withaferin A isolated from "Indian winter cherry". Yang H; Shi G; Dou QP Mol Pharmacol; 2007 Feb; 71(2):426-37. PubMed ID: 17093135 [TBL] [Abstract][Full Text] [Related]
4. Celastrol, a triterpene extracted from the Chinese "Thunder of God Vine," is a potent proteasome inhibitor and suppresses human prostate cancer growth in nude mice. Yang H; Chen D; Cui QC; Yuan X; Dou QP Cancer Res; 2006 May; 66(9):4758-65. PubMed ID: 16651429 [TBL] [Abstract][Full Text] [Related]
5. Curcumin inhibits the proteasome activity in human colon cancer cells in vitro and in vivo. Milacic V; Banerjee S; Landis-Piwowar KR; Sarkar FH; Majumdar AP; Dou QP Cancer Res; 2008 Sep; 68(18):7283-92. PubMed ID: 18794115 [TBL] [Abstract][Full Text] [Related]
6. Shikonin inhibits the growth of human prostate cancer cells via modulation of the androgen receptor. Jang SY; Jang EH; Jeong SY; Kim JH Int J Oncol; 2014 May; 44(5):1455-60. PubMed ID: 24573652 [TBL] [Abstract][Full Text] [Related]
7. Pristimerin induces apoptosis by targeting the proteasome in prostate cancer cells. Yang H; Landis-Piwowar KR; Lu D; Yuan P; Li L; Reddy GP; Yuan X; Dou QP J Cell Biochem; 2008 Jan; 103(1):234-44. PubMed ID: 17541980 [TBL] [Abstract][Full Text] [Related]
8. Studies of C-terminal naphthoquinone dipeptides as 20S proteasome inhibitors. Scotti A; Trapella C; Ferretti V; Gallerani E; Gavioli R; Marastoni M J Enzyme Inhib Med Chem; 2016; 31(3):456-63. PubMed ID: 25942361 [TBL] [Abstract][Full Text] [Related]
9. Shikonin enhances sensitization of gefitinib against wild-type EGFR non-small cell lung cancer via inhibition PKM2/stat3/cyclinD1 signal pathway. Tang JC; Ren YG; Zhao J; Long F; Chen JY; Jiang Z Life Sci; 2018 Jul; 204():71-77. PubMed ID: 29738778 [TBL] [Abstract][Full Text] [Related]
10. Shikonin inhibits thyroid cancer cell growth and invasiveness through targeting major signaling pathways. Yang Q; Ji M; Guan H; Shi B; Hou P J Clin Endocrinol Metab; 2013 Dec; 98(12):E1909-17. PubMed ID: 24106286 [TBL] [Abstract][Full Text] [Related]
11. Repurposing an antidandruff agent to treating cancer: zinc pyrithione inhibits tumor growth via targeting proteasome-associated deubiquitinases. Zhao C; Chen X; Yang C; Zang D; Lan X; Liao S; Zhang P; Wu J; Li X; Liu N; Liao Y; Huang H; Shi X; Jiang L; Liu X; Dou QP; Wang X; Liu J Oncotarget; 2017 Feb; 8(8):13942-13956. PubMed ID: 28086217 [TBL] [Abstract][Full Text] [Related]
12. Shikonin Promotes Skin Cell Proliferation and Inhibits Nuclear Factor-κB Translocation via Proteasome Inhibition In Vitro. Yan Y; Furumura M; Gouya T; Iwanaga A; Teye K; Numata S; Karashima T; Li XG; Hashimoto T Chin Med J (Engl); 2015 Aug; 128(16):2228-33. PubMed ID: 26265618 [TBL] [Abstract][Full Text] [Related]
13. Targeting Cell Necroptosis and Apoptosis Induced by Shikonin via Receptor Interacting Protein Kinases in Estrogen Receptor Positive Breast Cancer Cell Line, MCF-7. Shahsavari Z; Karami-Tehrani F; Salami S Anticancer Agents Med Chem; 2018; 18(2):245-254. PubMed ID: 28933271 [TBL] [Abstract][Full Text] [Related]
14. Shikonin inhibits gefitinib-resistant non-small cell lung cancer by inhibiting TrxR and activating the EGFR proteasomal degradation pathway. Li X; Fan XX; Jiang ZB; Loo WT; Yao XJ; Leung EL; Chow LW; Liu L Pharmacol Res; 2017 Jan; 115():45-55. PubMed ID: 27864022 [TBL] [Abstract][Full Text] [Related]
15. Shikonin Inhibits Tumor Growth in Mice by Suppressing Pyruvate Kinase M2-mediated Aerobic Glycolysis. Zhao X; Zhu Y; Hu J; Jiang L; Li L; Jia S; Zen K Sci Rep; 2018 Sep; 8(1):14517. PubMed ID: 30266938 [TBL] [Abstract][Full Text] [Related]
16. Shikonin inhibits prostate cancer cells metastasis by reducing matrix metalloproteinase-2/-9 expression via AKT/mTOR and ROS/ERK1/2 pathways. Chen Y; Zheng L; Liu J; Zhou Z; Cao X; Lv X; Chen F Int Immunopharmacol; 2014 Aug; 21(2):447-55. PubMed ID: 24905636 [TBL] [Abstract][Full Text] [Related]
17. SH-7, a new synthesized shikonin derivative, exerting its potent antitumor activities as a topoisomerase inhibitor. Yang F; Chen Y; Duan W; Zhang C; Zhu H; Ding J Int J Cancer; 2006 Sep; 119(5):1184-93. PubMed ID: 16570288 [TBL] [Abstract][Full Text] [Related]
18. Shikonin inhibits cancer cell cycling by targeting Cdc25s. Zhang S; Gao Q; Li W; Zhu L; Shang Q; Feng S; Jia J; Jia Q; Shen S; Su Z BMC Cancer; 2019 Jan; 19(1):20. PubMed ID: 30616572 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of proteasome activity by the dietary flavonoid apigenin is associated with growth inhibition in cultured breast cancer cells and xenografts. Chen D; Landis-Piwowar KR; Chen MS; Dou QP Breast Cancer Res; 2007; 9(6):R80. PubMed ID: 18300387 [TBL] [Abstract][Full Text] [Related]
20. Cadmium pyrithione suppresses tumor growth in vitro and in vivo through inhibition of proteasomal deubiquitinase. Chen X; Wu J; Yang Q; Zhang X; Zhang P; Liao S; He Z; Wang X; Zhao C; Liu J Biometals; 2018 Feb; 31(1):29-43. PubMed ID: 29098502 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]